In humans, a number of studies have shown that increased circulating RBP4 levels were correlated with obesity, insulin resistance, impaired glucose tolerance and type 2 diabetes mellitus (T2DM) [7–9]. Here, RBP4 is linked to obesity due to melanocortin 4 receptor deficiency.